Osteogenic sarcoma associated with diamond-blackfan anemia: A report from the diamond-blackfan anemia registry

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 1, 2001, Pages 39-44

  Lipton, Jeffrey M ^a   Federman, Noah ^b   Khabbaze, Youssef ^a   Schwartz, Cindy L ^c   Hilliard, Lee M ^d   Clark, Joseph I ^e   Vlachos, Adrianna ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Diamond Blackfan anemia; Malignancy; Osteogenic sarcoma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLACKFAN DIAMOND ANEMIA; CANCER RISK; CHILD; DATA BASE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; REGISTER;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD, PRESCHOOL; COLONIC NEOPLASMS; DATABASES, FACTUAL; DISEASE SUSCEPTIBILITY; FANCONI ANEMIA; FEMALE; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; OSTEOSARCOMA; REGISTRIES; RISK FACTORS; SARCOMA; UNITED STATES;

EID: 0035129306     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200101000-00009     Document Type: Article

References (39)

1. Lipton JM, Alter BP. Diamond Blackfan anemia. In: Feig SA, Freedman MH, eds. Clinical Disorders and Experimental Models of Erythropoietic Failure Boca Raton, FL: CRC Press Inc., 1993: 39-67.
2. Aquino VM, Buchanan GR. Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia. J Pediatr Hematol Oncol 1996; 18: 230-2.
3. Willig T-N, Niemeyer CM, Leblanc T, et al. Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. Pediatr Res 1999; 46: 553-61.
4. Vlachos A, Alter B, Buchanan G, et al. The Diamond Blackfan Anemia Registry (DBAR): Preliminary data [abstract]. Blood 1993; 82: 339a.
5. Diamond LK, Wang WC, Alter BP. Congenital hypoplastic anemia. Adv Pediatr 1976; 22: 349-78.
6. Steinherz PG, Canale VC, Miller DR. Hepatocellular carcinoma, transfusion induced hemochromatosis and congenital hypoplastic anemia (Diamond-Blackfan syndrome). Am J Med 1976; 60: 1032-4.
7. Seip M. Malignant tumors in two patients with Diamond-Blackfan anemia treated with corticosteroids and androgens. Pediatr Hematol Oncol 1994; 11: 423-6.
8. Janov A, Leong T, Nathan DG, et al. Diamond Blackfan anemia. Natural history and sequelae of treatment. Medicine (Baltimore) 1996; 75: 77-87.
9. Greinix HT, Storb R, Sanders JE, et al. Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome). Br J Haematol 1993; 84: 515-20.
10. Turcotte R, Bard C, Marton D, et al. Malignant fibrous histiocytoma in a patient with Blackfan-Diamond anemia. Can Assoc Radiol J 1994; 45: 402-4.
11. D’Oelsnitz ML, Vincent L, DeSwarte M, et al. A propos d’un cas de leucemie apres guerison d’une maladie de Blackfan-Diamond. Arch Fr Pediatr 1975; 32: 582.
12. Hayashi AK, Kang YS, Smith BM. Non-Hodgkin’s lymphoma in a patient with Diamond-Blackfan anemia. Am J Radiol 1998; 73: 117-8.
13. Frappaz, D, Richard O, Perrot S, et al. Maladie de Blackfan Diamond et malignite: relations de cause a effet? Pédiatrie 1992; 47: 535-40.
14. van Dikjen PJ, Verwijs W. Diamond-Blackfan anemia and malignancy. A case report and a review of the literature. Cancer 1995; 76: 517-20.
15. Krishnan EU, Wegner K, Garg SK. Congenital hypoplastic anemia terminating in acute promyelocytic leukemia. Pediatrics 1978; 61: 898-901.
16. Wasser JS, Yolken R, Miller DR, et al. Congenital hypoplastic anemia (Diamond-Blackfan syndrome) terminating in acute myelogenous leukemia. Blood 1978; 51: 991-5.
17. Basso G, Cocito MG, Refubbi L, et al. Congenital hypoplastic anemia developed in acute megakaryoblastic leukemia. Helv Paediatr Acta 1981; 36: 267-70.
18. Glader BE, Flam MS, Dahl GV, et al. Hematologic malignancies in Diamond-Blackfan anemia [abstract]. Pediatr Res 1990; 27: 142A.
19. Mori PG, Haupt R, Fugazza G, et al. Pentasomy 21 in leukemia complicating Diamond Blackfan anemia. Cancer Genet Cytogenet 1992; 63: 70-2.
20. th ed. Philadelphia: W.B. Saunders, 1991: 263-70.
21. Perdahl EB, Naprstek BL, Wallace WC, et al. Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. Blood 1994; 83: 645-50.
22. Zurlo MG, DeStefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassemia major. Lancet 1989; 2: 27-30.
23. Socie G, Henry-Amar M, Cosset JM, et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991; 78: 277-9.
24. Witherspoon RP, Storb R, Pepe M, et al. Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone. Blood 1992; 79: 289-92.
25. Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 1993; 329: 1152-7.
26. Scheven BA, Hamilton NJ, Fakkeldij TM, et al. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regul 1991; 1: 160-7.
27. Hansen MF, Koutos A, Gallie BL, et al. Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 1985; 82: 6216-20.
28. Toguchida J, Yamaguchi T, Ritchie B, et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcoma. Cancer Res 1992; 52: 6194-9.
29. Cumin I, Cohen JY, David A, et al. Rothmund-Thomson syndrome and osteosarcoma. Med Pediatr Oncol 1996; 26: 414-6.
30. Kerr B, Ashcroft GS, Scott D, et al. Rothmund-Thomson syndrome: two case reports show heterogeneous cutaneous abnormalities, an association with genetically programmed aging changes, and increased chromosomal radiosensitivity. J Med Genet 1996; 33: 928-34.
31. Friend SH, Horowitz JM, Gerber MR, et al. Deletions of DNA sequences in retinoblastoma and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci USA 1987; 84: 9059-63.
32. McIntyre JF, Smith-Sorensen B, Friend SH, et al. Germline mutations of the p53 tumor suppression gene in children with osteosarcoma J Clin Oncol 1994; 12: 925-30.
33. Yamaguchi T, Toguchida J, Yamamuro T, et al. Allelotype analysis in osteosarcoma: frequent allele loss on 3q, 13q, 17p and 18q. Cancer Res 1992; 52: 2419-23.
34. Gustavsson P, Willig T-N, van Haeringen A, et al. Diamond-Blackfan anemia: genetic homogenecity for a gene on chromosome 19q13 restricted to 1.8 Mb. Nat Genet 1997; 16: 368-71.
35. Gazda H, Lipton JM, Niemeyer CM, et al. Evidence for linkage of familial Diamond Blackfan anemia to chromosome 8p23.2-23.1 and non-19q non-8p disease [abstract]. Blood 1999; 94: 673a.
36. Draptchinskaia N, Gustavsson P, Anderson B, et al. The ribosomal protein S19 gene is mutated in Diamond-Blackfan anemia. Nat Genet 1999; 21: 169-75.
37. Kruzelock RP, Murphy EC, Strong LC, et al. Localization of a novel tumor suppressor loci on human chromosome 3q important in osteosarcoma tumorigenesis. Cancer Res 1997; 57: 106-9.
38. Ireland M, English C, Cross I, et al. A de novo translocation t(3;17) (q26.3;q23.1) in a child with Cornelia deLange syndrome. J Med Genet 1991; 28: 639-40.
39. Diamond LK, Blackfan KD. Hypoplastic anemia. Am J Dis Child 1938; 56;464-7.